| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.061 | 0.3 |